Spinning out your research – the journey of an academic entrepreneur Are you considering spinning out your research? Taking a […]
Spinning out your research – the journey of an academic entrepreneur
Join us for talks, case studies and advice to inspire academics and researchers to create impact from research through the formation of spin out companies.
Jointly hosted by Cambridge Innovation Capital and Cambridge Enterprise
17 October 2023
Howard Theatre, Downing College, Regent Street, Cambridge, CB2 1QF
This event brings together entrepreneurs from a variety of backgrounds, who will share their enterprise experiences and spin-out journeys, together with the networks, accelerators and investors who helped and advised them. There will be plenty of opportunity to ask questions, and to network during the breaks and at the drinks reception.
As this event has been oversubscribed in previous years, priority will be given to early stage academic entrepreneurs and academic researchers, PostDocs and PhDs.
Agenda
14.45 – Registration and refreshments
15.15 – Welcome
Professor Andy Neely, Senior Pro-Vice-Chancellor, and Professor of Manufacturing at the University of Cambridge
15.25 – Founder talk – NoBACZ Healthcare
Dr Jonathan Powell, Founder and CEO
Dr Laura Donnelly, Commercialisation Manager at Cambridge Enterprise
15.45 – Founder talk – Nu Quantum
Dr Carmen Palacios-Berraquero, Founder and CEO
Dr Elaine Loukes, Investment Director, Cambridge Enterprise
16.05 – Founder talk – StemBond Technologies
Dr Andrew Hodgson, Founder and CEO
Dr Jason Mellad, Founder and CEO, Start Codon
16.25 – Founder talk – Mosaic Therapeutics
Dr Mathew Garnett, Co-Founder
Dr Anne Horgan, Partner, Cambridge Innovation Capital
16.45 – Q&A panel – Founders
Dr Jonathan Powell, Founder and CEO, NoBACZ Healthcare
Dr Carmen Palacios-Berraquero, Founder and CEO
Dr Andrew Hodgson, Founder and CEO, StemBond Technologies
Dr Mathew Garnett, Co-Founder, Mosaic Therapeutics
Facilitated by Dr Phil Elstob, Commercialisation Director, Cambridge Enterprise
17.05 – Q&A panel – Accelerators, investors and advisors
Dr Laura Donnelly, Commercialisation Manager, Cambridge Enterprise
Dr Elaine Loukes, Investment Director, Cambridge Enterprise
Dr Jason Mellad, Founder and CEO, Start Codon
Dr Anne Horgan, Partner, Cambridge Innovation Capital
Facilitated by Dr Robert Tansley, Partner, Cambridge Innovation Capital
17.25 – Closing comments
17.30 – Networking drinks
Please register your attendance by 6 October 2023
About Cambridge Innovation Capital
Cambridge Innovation Capital (CIC) is a leading venture investor backing and building category-leading deep tech and life sciences companies. CIC currently manages in excess of £0.5 billion and has invested in around 40 companies. CIC is a preferred investor for the University of Cambridge, Europe’s top source of founders for venture-backed start-ups.
Cambridge Innovation Capital Manager Limited (FRN:918898) is authorised and regulated by the Financial Conduct Authority.
For more information, please visit www.cic.vc or follow us on Twitter at @CIC_vc and LinkedIn.
About Cambridge Enterprise
Part of the University of Cambridge, Cambridge Enterprise supports academics, researchers, staff and students in achieving knowledge transfer and research impact. We do this by helping innovators, experts and entrepreneurs use commercial avenues to develop their ideas and expertise for the benefit of society, the economy, themselves and the University.
Liaising with organisations both locally and globally, we offer expert advice and support in commercialisation and social enterprise, including help with academic consultancy services, the protection, development and licensing of ideas, new company and social enterprise creation, and seed funding.
For more information, please visit www.enterprise.cam.ac.uk or follow us on Twitter @ucamenterprise and Linkedin.